Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

NCT00537056 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00537056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2007
Completion date
April 30, 2012
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell, kidney (renal cell) cancer, kidney neoplasms